RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
EUR 13.8
(-1.43%)
EUR 13.8
(-1.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -56.2 Million EUR | -169.5% |
| 2022 | 80.86 Million EUR | 141.77% |
| 2021 | 33.44 Million EUR | -51.98% |
| 2020 | 69.64 Million EUR | 56.49% |
| 2019 | 44.5 Million EUR | 266.17% |
| 2018 | -26.78 Million EUR | 77.41% |
| 2017 | -118.55 Million EUR | -77.17% |
| 2016 | -66.91 Million EUR | -454.42% |
| 2015 | 18.88 Million EUR | 103.52% |
| 2014 | -536.09 Million EUR | -168.56% |
| 2013 | 781.94 Million EUR | -2.45% |
| 2012 | 801.57 Million EUR | 267.86% |
| 2011 | -477.53 Million EUR | -14.86% |
| 2010 | -415.74 Million EUR | 6.56% |
| 2009 | -444.92 Million EUR | -169.21% |
| 2008 | 642.86 Million EUR | 478.03% |
| 2007 | -170.05 Million EUR | 3.45% |
| 2006 | -176.13 Million EUR | 30.75% |
| 2005 | -254.34 Million EUR | -271.33% |
| 2004 | -68.49 Million EUR | -187.87% |
| 2003 | 77.94 Million EUR | -39.99% |
| 2002 | 129.88 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -82.15 Million EUR | -46.17% |
| 2024 Q2 | -100.44 Million EUR | -22.26% |
| 2023 Q4 | -56.2 Million EUR | -1605.25% |
| 2023 Q3 | -3.29 Million EUR | 95.16% |
| 2023 Q2 | -68.06 Million EUR | -209.51% |
| 2023 Q1 | 62.15 Million EUR | -23.14% |
| 2023 FY | -56.2 Million EUR | -169.5% |
| 2022 Q2 | 57.92 Million EUR | 162.44% |
| 2022 Q4 | 80.86 Million EUR | 8.79% |
| 2022 Q3 | 74.33 Million EUR | 28.31% |
| 2022 Q1 | 22.07 Million EUR | -34.01% |
| 2022 FY | 80.86 Million EUR | 141.77% |
| 2021 Q2 | -170.8 Million EUR | -676.19% |
| 2021 FY | 33.44 Million EUR | -51.98% |
| 2021 Q4 | 33.44 Million EUR | 198.88% |
| 2021 Q1 | 29.64 Million EUR | -57.44% |
| 2021 Q3 | 11.19 Million EUR | 106.55% |
| 2020 Q2 | 37.95 Million EUR | 10.33% |
| 2020 Q1 | 34.39 Million EUR | -22.71% |
| 2020 Q3 | -104.18 Million EUR | -374.53% |
| 2020 Q4 | 69.64 Million EUR | 166.85% |
| 2020 FY | 69.64 Million EUR | 56.49% |
| 2019 Q1 | 25.92 Million EUR | 196.79% |
| 2019 FY | 44.5 Million EUR | 266.17% |
| 2019 Q2 | 5.72 Million EUR | -77.9% |
| 2019 Q3 | -102.38 Million EUR | -1887.17% |
| 2019 Q4 | 44.5 Million EUR | 143.47% |
| 2018 Q3 | -69.85 Million EUR | 30.26% |
| 2018 Q4 | -26.78 Million EUR | 61.66% |
| 2018 FY | -26.78 Million EUR | 77.41% |
| 2018 Q1 | -101.58 Million EUR | 14.31% |
| 2018 Q2 | -100.16 Million EUR | 1.4% |
| 2017 Q4 | -118.55 Million EUR | 4.22% |
| 2017 FY | -118.55 Million EUR | -77.17% |
| 2017 Q1 | -87.54 Million EUR | -30.83% |
| 2017 Q3 | -123.77 Million EUR | -22.62% |
| 2017 Q2 | -100.93 Million EUR | -15.3% |
| 2016 FY | -66.91 Million EUR | -454.42% |
| 2016 Q1 | -47.87 Million EUR | -353.57% |
| 2016 Q4 | -66.91 Million EUR | 5.41% |
| 2016 Q2 | -45.09 Million EUR | 5.8% |
| 2016 Q3 | -70.73 Million EUR | -56.86% |
| 2015 FY | 18.88 Million EUR | 103.52% |
| 2015 Q4 | 18.88 Million EUR | 105.88% |
| 2015 Q3 | -321.13 Million EUR | -112.52% |
| 2015 Q2 | -151.1 Million EUR | 20.66% |
| 2015 Q1 | -190.45 Million EUR | 64.47% |
| 2014 Q2 | -2.11 Billion EUR | 1.97% |
| 2014 Q3 | -2.15 Billion EUR | -1.7% |
| 2014 Q1 | -2.16 Billion EUR | -376.37% |
| 2014 Q4 | -536.09 Million EUR | 75.12% |
| 2014 FY | -536.09 Million EUR | -168.56% |
| 2013 Q2 | 800.26 Million EUR | -0.07% |
| 2013 FY | 781.94 Million EUR | -2.45% |
| 2013 Q1 | 800.8 Million EUR | -0.1% |
| 2013 Q4 | 781.94 Million EUR | 3.59% |
| 2013 Q3 | 754.85 Million EUR | -5.67% |
| 2012 Q2 | -358.51 Million EUR | 0.62% |
| 2012 Q3 | -187.43 Million EUR | 47.72% |
| 2012 Q4 | 801.57 Million EUR | 527.67% |
| 2012 FY | 801.57 Million EUR | 267.86% |
| 2012 Q1 | -360.73 Million EUR | -165.37% |
| 2011 Q3 | -369.7 Million EUR | -2.62% |
| 2011 Q4 | 551.86 Million EUR | 249.27% |
| 2011 FY | -477.53 Million EUR | -14.86% |
| 2011 Q1 | -395.17 Million EUR | 4.95% |
| 2011 Q2 | -360.26 Million EUR | 8.83% |
| 2010 Q4 | -415.74 Million EUR | -2.96% |
| 2010 FY | -415.74 Million EUR | 6.56% |
| 2010 Q1 | -470.11 Million EUR | -5.66% |
| 2010 Q3 | -403.8 Million EUR | 0.8% |
| 2010 Q2 | -407.05 Million EUR | 13.41% |
| 2009 Q4 | -444.92 Million EUR | 0.0% |
| 2009 FY | -444.92 Million EUR | -169.21% |
| 2008 FY | 642.86 Million EUR | 478.03% |
| 2007 FY | -170.05 Million EUR | 3.45% |
| 2006 FY | -176.13 Million EUR | 30.75% |
| 2005 FY | -254.34 Million EUR | -271.33% |
| 2004 FY | -68.49 Million EUR | -187.87% |
| 2003 FY | 77.94 Million EUR | -39.99% |
| 2002 FY | 129.88 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.64 Billion EUR | 100.528% |
| Fresenius SE & Co. KGaA | 13.54 Billion EUR | 100.415% |
| LIMES Schlosskliniken AG | 1.57 Million EUR | 3677.291% |
| M1 Kliniken AG | -5.33 Million EUR | -953.18% |
| Maternus-Kliniken Aktiengesellschaft | 111.79 Million EUR | 150.273% |
| MEDICLIN Aktiengesellschaft | 364.53 Million EUR | 115.418% |
| VITA 34 AG | 4.15 Million EUR | 1451.407% |